Lobo, the chair and CEO of orthopedic and surgical device giant Stryker (NYSE: SYK) , brings more than 25 years of medtech, operational and financial leadership experience. He offers clinical expertise and a track record of driving innovation and scaling global businesses.
“Kevin is a seasoned healthcare executive with a deep understanding of the medical technology landscape. His knowledge and insight will further strengthen our Board as we continue to build a more personalized, connected and sustainable future for healthcare,” said H. Lawrence Culp, Jr., board chair, GE HealthCare. “We look forward to benefiting from his perspective as we execute on our growth and innovation priorities.”
Lobo took over the corner office at Stryker in October 2012. Before this, he held leadership positions within Stryker’s Orthopedics Group and Neurotechnology and Spine Group.
Previous experience for Lobo includes time at J&J, including as president of Ethicon Endo Strategy and Rhône-Poulenc, a chemical and pharmaceutical company.
Earlier in his career, he held finance roles of increasing responsibility at KPMG, Unilever and Kraft Canada.
“GE HealthCare plays a critical role in shaping the future of healthcare through advanced technology, novel pharmaceutical diagnostics, and global reach,” Lobo said. “I look forward to serving on its board and working with the management team as it executes on its strategy to enable more precise patient care, drive growth, and create long-term value.”
